Eculizumab therapy and complement regulation in a case of resistant catastrophic antiphospholipid syndrome., PMID:38442982
Impact of Methylthioxylose Substituents on the Biological Activities of Lipomannan and Lipoarabinomannan in Mycobacterium tuberculosis., PMID:38511206
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria., PMID:38534211
Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry"., PMID:38552300
Antiphospholipid syndrome in the era of COVID-19 - Two sides of a coin., PMID:38604461
Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?, PMID:38652403
Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability-Brief Report., PMID:38695172
Management of Anticoagulation and Antifibrinolytics in Catastrophic Antiphospholipid Syndrome., PMID:38705843
Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics., PMID:38713502
Pediatric catastrophic antiphospholipid syndrome with extensive skin involvement., PMID:38783589
Triumph Over Adversity: A Comprehensive Case Series on Successful Pregnancy Outcomes in Antiphospholipid Antibody (APLA)-Positive Patients., PMID:38803763
NLRP3 Inflammasome in Autoinflammatory Diseases and Periodontitis Advance in the Management., PMID:38882867
Histologic Analysis of 'Distraction Vaginogenesis' in a Rat Model., PMID:38921727
Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome., PMID:38940218
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markers., PMID:38970372
Systemic Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke: A Case of Suspected Catastrophic Antiphospholipid Syndrome., PMID:39040914
Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients., PMID:39073513
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies., PMID:39096716
Redesigning amino/carboxyl ends of DARPin G3 for high thermostability and production in tobacco transplastomic plants., PMID:39126530
Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition., PMID:39130941
Selective inhibition of interleukin 6 receptor decreased inflammatory cytokines and increased proteases in an experimental model of critical calvarial defect., PMID:39166608
Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry"., PMID:39174151
Antiphospholipid Syndrome and Catastrophic Antiphospholipid Syndrome: A Comprehensive Review of Pathogenesis, Clinical Features, and Management Strategies., PMID:39252716
Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome., PMID:39318635
Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China., PMID:39334417
Cell-bound complement activation products in antiphospholipid antibody-positive patients without other systemic autoimmune rheumatic diseases., PMID:39355252
Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing., PMID:39381601
Directed evolution of an orthogonal transcription engine for programmable gene expression in eukaryotes., PMID:39386662
Catastrophic Antiphospholipid Syndrome: A Review of Current Evidence and Future Management Practices., PMID:39429267
Seronegative Catastrophic Antiphospholipid Syndrome: A Case Report of a Deadly Diagnosis., PMID:39493117
Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice., PMID:39531316
Catastrophic antiphospholipid syndrome: a CAPS-tivating hematologic disease., PMID:39644034
Development and application of an uncapped mRNA platform., PMID:39648715
The evaluation of DNA-linked inhibitor antibody and AlphaScreen assays for high-throughput screening of compounds targeting the cap-binding domain in influenza a polymerase., PMID:39674552
Catastrophic antiphospholipid syndrome of pregnancy with acute massive cerebral infarction: A case report., PMID:39686499
Determination of the decapping efficiency of THIOMAB™ antibodies with the engineered cysteine in the Fc region for making antibody-drug conjugates by specific hinge fragmentation-liquid chromatography., PMID:39688670
Case Report: Primary catastrophic antiphospholipid syndrome in a pediatric patient with cerebral venous sinus thrombosis as the first manifestation., PMID:39722765
Dual-Enzyme-Instructed Peptide Self-Assembly to Boost Immunogenic Cell Death by Coordinating Intracellular Calcium Overload and Chemotherapy., PMID:39754594
Case Report: Catastrophic antiphospholipid syndrome in a pediatric patient after percutaneous treatment of aortic re-coarctation., PMID:39764168
Directed evolution of an orthogonal transcription engine for programmable gene expression in eukaryotes., PMID:39811667
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment., PMID:39973823
Multi-centered clinical validation demonstrating superior precision in lupus diagnosis: T cell autoantibodies and TC4d outperform conventional lupus erythematosus biomarkers., PMID:40093011
Catastrophic antiphospholipid syndrome presenting with a stroke as a first presentation: case report., PMID:40124700
Coronavirus disease 2019 and catastrophic antiphospholipid syndrome: Case report., PMID:40153768
Case Report: Primary adrenal insufficiency due to bilateral adrenal infarction and antiphospholipid syndrome in Covid19 - A complicate case of cardiogenic shock., PMID:40241990
Primary Catastrophic Antiphospholipid Syndrome With Multiple Infarcts in the Kidney, Liver, and Spleen in a Healthy Young Man: A Case Report., PMID:40322451
Association of cancer and anti-synthetase syndrome: a retrospective multicentre study., PMID:40460913
Complex presentation of probable catastrophic antiphospholipid syndrome: diagnostic dilemmas and treatment strategies., PMID:40484440
Catastrophic Antiphospholipid Syndrome Following Treated Antineutrophilic Cytoplasmic Antibody (ANCA) Vasculitis: Unusual Case Presentation., PMID:40486372
IL-18 inhibition enlarges lesions, necrotic cores and thickens fibrous caps in Jak2 V617F clonal hematopoiesis-driven atherosclerosis., PMID:40501724
For research use only. Not for human or drug use.
